By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Elcelyx Therapeutics 



San Diego  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Elcelyx Therapeutics Announces Positive Results in Phase 2b Study of NewMet in Type 2 Diabetes 10/21/2013 8:48:10 AM
Elcelyx Therapeutics to Present Clinical Data on NewMet in Type 2 Diabetes at the 49th Annual European Association for the Study of Diabetes Meeting 9/17/2013 9:27:39 AM
Elcelyx Therapeutics' NewMet for Type 2 Diabetes Meets Primary Endpoint in Phase 2b Study 9/4/2013 9:57:19 AM
NaZura BioHealth Spun-Out From Elcelyx Therapeutics to Advance Lovidia for Weight Management 9/4/2013 6:56:09 AM
Elcelyx Therapeutics' Study Shows NewMet Has Better Glucose-Lowering Effects Than Metformin 6/24/2013 6:49:27 AM
Elcelyx Therapeutics to Present Clinical Data on NewMet™ in Type 2 Diabetes at the 2013 American Diabetes Association Scientific Sessions 6/17/2013 8:43:24 AM
Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 5/20/2013 1:52:58 PM
Elcelyx Therapeutics Closes on $20 Million to Advance Appetite-Control Compounds 2/14/2013 6:58:03 AM
Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors 8/13/2012 9:56:29 AM
Elcelyx Therapeutics Raises $4 Million 8/13/2012 7:45:21 AM
12
//-->